The Trade-Off Arrived: Bromethalin, Pets, and What Happened After Anticoagulants Left the Shelf

1. Introduction: a prediction we made in passing

Our article Where the Residue Goes weighed the alternatives to persistent anticoagulant rodenticides and noted a trade-off: the options gentler on wildlife are harsher on pets, because they lack an antidote. We made the point as reasoning. This article looks at what happened when regulators made the trade.

1.0b And a follow-up rather than a new argument

The reasoning is the earlier article's. What this one adds is the regulatory sequence and the data that followed, and we say so at the outset because the earlier article is the reason this one exists.

1.1 Which is the trade-off, observed

Not a prediction any more, but a documented shift in what poisons pets.

1.1b In both countries

The American and Canadian regulators made the same move within two years of each other, so the consumer shelf on both sides of the border changed in the same direction.⁶⁸

1.2 What this article argues

That the substitution was predicted, that it happened, and that the resulting structure placed each risk with a different buyer and a different victim. Sections 10, 11 and 19 are the case.

2. What the earlier article argued

In its own words.

That article found non-anticoagulant options less persistent in wildlife and lacking an antidote, and concluded that the option that is gentler on the raptor eating a poisoned rat is harsher on the pet that eats the bait directly.

2.0b And it made the point as one line in a longer weighing

Alongside exclusion, rotation and the wildlife residue evidence, which is why a separate article on the pet side is warranted.

2.1 Anticoagulant poisoning has a treatment

Because vitamin K addresses the pathway the compound blocks, a dog that eats anticoagulant bait can be treated. That was the earlier article's reason for the trade-off, and it remains the mechanism.

2.2 The earlier article also named the other alternative

Cholecalciferol, which kills by raising calcium rather than by blocking clotting, and which our treadmill article noted has its own non-target profile, particularly for dogs.

3. What regulators did

In the United States.

In 2008 the environmental regulator issued a risk mitigation decision for ten rodenticides, and manufacturers may no longer sell consumer products containing the four second-generation anticoagulants that pose the greatest risk to non-target wildlife, although baits containing these poisons may still be used in homes by pest control professionals.⁶

3.0b Driven by litigation

The regulator describes the 2008 decision as its final action in response to a court remand in a case brought by an environmental justice organisation and a national environmental group, with measures to reduce risks to human health and non-target organisms.⁶

3.0c And a size limit

Consumer products may no longer be sold with more than a pound of poison.⁶

3.1 Implemented over several years

Drafted in 2008 and attempted by 2011, according to one veterinary reference.⁴

3.2 And contested

A major consumer brand's manufacturer said in 2013 that it would vigorously challenge the regulator's actions,⁵ and one Canadian guide records that the brand dropped second-generation anticoagulants from its American consumer products in 2015.¹⁴

4. In Canada

Two years later.

Following the American decision, the Canadian regulator required additional measures in 2010 under which SGARs were prohibited for domestic class products, meaning those intended for use by consumers in and around the home, while commercial class products containing them were labelled for use only by certified pest control operators, farmers and authorised programmes.⁸

4.0b And limits on professional outdoor use

Two of the compounds were restricted to indoor use, and outdoor use of a third limited to within 15 metres of a structure, or 100 metres in a secured bait station.⁸

4.1 With bait stations for consumers

Consumer products must be sold packaged with a bait station meeting the stated requirements.¹⁰

4.1b And a wider list of actives

The Canadian measures covered brodifacoum, bromadiolone, bromethalin, chlorophacinone, diphacinone, difethialone, warfarin and zinc phosphide, so the whole consumer category was reshaped.⁹

4.2 The effective dates differ between sources

One account gives January 2013 for the measures taking effect, and a manufacturer's notice says that after 30 June 2014 only conforming domestic products would be available at retail.¹⁰¹¹

5. Who kept what

Our summary.

In both countries the persistent chemistry left the consumer shelf and stayed in professional hands. Consumers were left with first-generation anticoagulants and non-anticoagulants, in bait stations.⁶⁸

5.3 A deliberate asymmetry

Neither regulator hid it: the persistent compounds remain available to professionals by design, as the American regulator states and the Canadian measures provide.⁶⁸

5.1 The same structure in both countries

Which is not surprising, since the Canadian measures followed the American decision and drew on the same incident evidence.⁸⁹

5.1b Consumers kept the older anticoagulants

Warfarin, chlorophacinone and diphacinone remained on consumer shelves in Canada alongside bromethalin, all in bait stations.¹⁴

5.2 And a single variable separated the two groups

Certification. The chemistry available to a person now depends on whether they hold a licence, which is the supply control our phosphide article found to be the real safeguard.

6. What bromethalin is

Bromethalin is a neurotoxin that may cause cerebral edema, available in blocks, soft baits, pellets and other forms at concentrations from 0.01 to 0.025 per cent.³

6.0a In many forms

Blocks, soft baits, pellets, worms and seed, which gives a pet several shapes of product to find attractive.³

6.0b Usually eaten directly

Non-target animals are typically exposed by unintended direct ingestion of the bait, and only rarely by malicious intent.³

6.1 Fast, by rodenticide standards

A regulatory risk assessment describes it as fairly fast-acting, with signs of toxicity within the first 24 hours and death two to four days after exposure.¹³

7. Where it came from

An answer to an earlier problem.

Bromethalin was developed in the mid-1970s in response to warfarin-resistant rodents.³ Resistance to the first anticoagulants led to both bromethalin and the second-generation anticoagulants.⁴

7.0b With a strong claim attached

The reference records that it was touted at the time as having almost 90 per cent efficacy in rodent control, which is the kind of promotional figure our efficacy articles treat with care.³

7.1 So the two alternatives share an origin

Both were answers to resistance, which our treadmill article traced for the anticoagulant branch.

7.2 And both are now at the centre of the trade-off

One kept for professionals, one sold to householders, both descended from the same response to resistance.⁴

8. Why its lack of an antidote is the problem

Stated plainly.

Treatment for bromethalin poisoning typically involves repeated activated charcoal over a day; early treatment usually provides good outcomes, but animals that have signs of toxicosis before treatment can sustain permanent neurologic damage.⁵

8.0a Early is the only window

Decontamination before signs appear is what gives good outcomes, and the difficulty is that signs may take days, so an owner who did not see the pet eat the bait may miss the window.⁵¹

8.0b And treatment is more difficult

The helpline director described treating bromethalin poisoning as more difficult, time-consuming and often more expensive than treating anticoagulant poisoning.⁵

8.1 There is nothing to reverse it

Vitamin K reverses anticoagulant poisoning. Nothing reverses a brain that has swollen.

That contrast is ours.

9. Why it is hard to diagnose

Veterinary neurologists writing in a trade publication say it is difficult to prove intoxication, that signs may not develop for days and may progress slowly at first, and that the results of minimal database tests are typically normal.¹

9.0a Cats as well as dogs

The neurologists report studying five cats in six months with bromethalin intoxication resulting in severe neurological signs and death.¹

9.0b So a case can go unrecognised

An animal with delayed, slowly worsening neurological signs and normal blood work may not prompt anybody to think of rat bait, which the neurologists say lowers the index of suspicion.¹

9.0c Which makes witnesses important

An antemortem diagnosis can be made presumptively if somebody saw the animal eat the product, which puts much of the diagnostic weight on the owner's account.¹

9.1 A dye helps

The regulator requires an indicator dye in consumer rodenticides, and green-blue dye in vomit or faeces can imply ingestion.¹

10. The prediction before the fact

Made in 2013.

The assistant director of veterinary services at a pet poison helpline said she expects that the public will sharply increase use of rodenticides containing bromethalin if the regulator succeeded in removing a major brand's anticoagulant products, and worried that veterinarians might not know bromethalin use was increasing.⁵

10.0b And flagged a knowledge gap

Her concern was not only the shift but that many veterinarians might not know it was happening, which matters for a poison that is hard to recognise in the first place.⁵

10.1 An animal welfare organisation said the same

Warning that increased regulation of anticoagulants could lead to increased use of bromethalin and cholecalciferol.⁵

10.2 Cholecalciferol was not yet on consumer shelves

The same report noted that no rodenticides then marketed for consumer use contained cholecalciferol, so its later appearance in the poison control data reflects products that arrived after 2013.⁵⁷

The inference from the two dates is ours.

10.3 Which is unusual in the evidence we handle

A prediction about a pest control intervention made in public before the event and then borne out by later data, rather than an explanation assembled afterwards.⁵⁷

11. What the poison control data show

Over a decade.

Since the ruling, there has been a shift in the types of rodenticide toxicoses reported to a national animal poison control centre: between 2010 and 2020, reported bromethalin and cholecalciferol exposures increased and anticoagulant exposures decreased.⁷

11.0b Shown in a table

The case report presents the shift in a table of reported exposures by rodenticide type across the decade.⁷

11.1 Rising and falling together

Non-anticoagulant exposures up and anticoagulant exposures down over the same decade, which is the signature of substitution rather than of a general rise in poisoning.⁷

11.2 From a national centre

A poison control centre operated by a national animal welfare organisation, which receives calls from owners and veterinarians across the country.⁷

The description of how the centre receives cases is ours.

12. What the veterinary reference says

Quoted in §1.

The reference states that bromethalin quickly became the most common rodenticide exposure in companion animals after enforcement began.³

12.0a From a standard veterinary reference

A widely used manual rather than a single study, which means the statement reflects the reference's reading of the evidence as a whole.³

12.0b And quickly is the notable word

The change in what poisons pets followed the change in what was sold, without the delay one might expect from people using up old stock.³

That reading is ours.

12.1 Most common is a ranking, not a rate

It says bromethalin displaced other rodenticides among exposures, not how many animals were exposed.

13. One laboratory's numbers

A 14-year retrospective study from a state veterinary laboratory system reports the 2.8-fold increase in submitted cases from 2010–2016 to 2017–2023 (from 59 to 164 cases, respectively).²

13.0b Fourteen years of records

From 2010 to 2023, spanning the period before and after the consumer market changed, which is what makes a before and after comparison possible.²

13.1 More dogs than cats

With 25 per cent more dog cases than cat cases submitted, a median dog age of three and cats significantly younger.²

13.1b Young animals

A median dog age of three years and cats younger still, which fits animals curious enough to investigate a station.²

The behavioural reading is ours.

13.2 A single state system

One laboratory network in one state, so the figure describes what reached that laboratory rather than a national pattern.²

14. What those numbers can and cannot show

Our caution.

Laboratory submissions depend on veterinarians suspecting the poison and sending samples. Greater awareness, or a better test, would raise submissions without any change in how often animals are poisoned.

14.0b Submission is also a cost decision

An owner must agree to pay for testing, often after an animal has died, which adds another filter between a poisoning and a laboratory record.

That point is ours.

14.1 And a detection method exists

The study's reference list includes a method for detecting desmethylbromethalin, a metabolite, in animal tissue to determine exposure, which is the kind of development that increases submissions.¹²

14.1b Awareness would also rise with the substitution

More bromethalin on shelves means more veterinary attention to it, which would raise submissions even if poisonings rose less than the figure suggests. The two effects cannot be separated from these data.

That reasoning is ours.

14.2 So the rise is consistent with the substitution

Without proving its size. Together with the poison control shift and the reference ranking, the direction is not in doubt; the magnitude is.

15. People too

Briefly.

The same study describes a rise in human and animal exposure to bromethalin since the restriction, and its reference list includes a study of medical outcomes of bromethalin exposures reported to American poison centres after the federal restriction of anticoagulants.²¹²

15.1 We did not read that study

So we report only that it exists.

15.2 Children are the obvious concern

The restrictions were framed around exposure of children as well as pets and wildlife, and a consumer poison without an antidote raises the same question for a toddler as for a dog.¹²

The second clause is ours; we have no human outcome figures.

16. The diagnostic trap it created

A case from a veterinary journal.

With the increase in non-anticoagulant exposures, neurological signs in one dog were initially assumed to be bromethalin toxicosis, but the rodenticide was identified during treatment as a long-acting first-generation anticoagulant that had caused presumptive bleeding in the central nervous system.⁷

16.0b The two poisons can look alike

Bleeding inside the skull can produce neurological signs resembling those of bromethalin, which is the confusion the case describes.⁷

16.0c A first-generation product

The case involved a long-acting first-generation anticoagulant, the kind still sold to consumers, which shows the antidote-bearing products remain in homes too.⁷

16.0d Which affects treatment directly

An anticoagulant case mistaken for bromethalin could miss the vitamin K it needs, which is the one poisoning in this pair that can be reversed.⁷

The consequence is our inference from the case.

16.1 A shifted default

When one poison becomes the usual cause, clinicians expect it, and an anticoagulant case presenting unusually can be misread. The authors call for accurate product identification in suspected toxicosis.⁷

17. The antidote is not free either

Which the earlier article did not stress.

Second-generation anticoagulants have long half-lives and extended presence in body tissues, and treatment can require weeks or months of vitamin K administration and monitoring of blood parameters.⁵

17.1 And the persistent compounds are much more potent

The second-generation anticoagulants have median lethal doses 2.5 to 200 times lower than first-generation products, with a narrower safety margin.⁴

17.1b Which the regulator itself noted

The long half-lives and extended tissue presence of the persistent compounds are the regulator's own description, cited in the 2013 veterinary report.⁵

17.2 So the antidote was treating a stronger poison

Which is part of why treatment ran to weeks or months: the compound lingers and is potent while it does.⁵

The connection between the two facts is ours.

18. Which makes the trade-off real

Our assessment.

Neither class is simply safer. The anticoagulant can be reversed but at length and expense, and it persists in wildlife. Bromethalin clears from the environment more readily but cannot be reversed once the brain is affected.

18.1 A regulator had to choose

And chose to protect wildlife from the persistent compounds at the cost of pets meeting a compound without an antidote.

18.1a Every rodenticide is a choice of casualty

A poison designed to kill mammals will kill other mammals that eat it, and the only question regulation can settle is which ones are most likely to.

That framing is ours.

18.1b And the wildlife side had its own evidence

Our earlier article reported brodifacoum in about three quarters of owls in one study, with many above levels associated with health effects, which is the harm the restriction was meant to reduce.

18.2 We do not say it chose wrongly

The wildlife harm our earlier article documented is real, and the choice has a defensible logic.

19. Who got which risk

Our reading of the structure.

19.1 A clean split is a simplification

Consumer first-generation anticoagulants still reach wildlife through poisoned rodents, and professional bait can still be found by pets, so the chart shows the tendency rather than a boundary.

19.2 But the tendency is the point

The regulation moved the most persistent compounds away from the least trained users, and the compound that replaced them carries the risk the persistent ones did not.

20. Which is a choice about victims

Our argument.

Moving persistent compounds off the consumer shelf shifted the likely victims of consumer bait from predators such as owls toward dogs and cats in the same homes, because the bait that came to dominate is the kind a pet cannot be rescued from late.

20.1 A legitimate choice

Owls poisoned by prey carrying persistent residues are harmed without anybody choosing to expose them. A pet exposed to bait in its own home has an owner who can place the bait out of reach and seek treatment quickly.

20.1b And the pet owner can act

Seeing a dog at a station, an owner can seek treatment within the window. Nobody is watching the owl that ate a poisoned rat.

20.2 Which is the case for the decision

Putting the risk where somebody is positioned to manage it, which is a reasonable principle even if the management often fails.

Sections 20.1 and 20.2 are our reconstruction of the argument, not the regulator's stated reasoning.

21. And a choice about buyers

Also ours.

Professionals kept the persistent compounds and the antidote that goes with them. Householders kept first-generation anticoagulants, which also have an antidote, and gained a compound without one that became the dominant consumer product.¹⁴³ The product most dangerous to pets went to the least trained user, though in a tamper-resistant station.

21.0a Training is not the only safeguard lost

A licensed applicator also chooses where bait goes and can be held to account for it. A householder placing a station has neither the training nor the accountability.

That contrast is ours.

21.0b Which inverts the usual logic of access

Ordinarily the most dangerous products are the ones restricted to professionals. Here the product most dangerous to pets is the one sold to the public, because the regulatory concern was a different animal.

That observation is ours.

21.1 The station is the mitigation

Which is why consumer products must now come in bait stations, and why a station that is opened, broken or bypassed defeats the whole arrangement.¹⁰

22. What the Canadian regulator weighed

Evidence across the border.

The measures covered several actives including bromethalin, and reports of incidental exposure from Canada and the United States were considered in the evaluation, given the similar use patterns for these products in the two countries.⁹

22.0b Evaluated for value as well as risk

The measures are described as resulting from an evaluation of risks and of the product's contribution to pest management, which is the Canadian value requirement our efficacy article described.⁹

22.1 Which justifies reading the American data here

If the regulator treated use patterns as similar enough to pool incident evidence, the American exposure shift is a reasonable guide to what happened in Canada, though not a measurement of it.⁹

22.2 And bromethalin was among the actives regulated

The Canadian measures listed it alongside the anticoagulants and zinc phosphide, so its consumer use here also comes with restrictions.⁹

23. The Canadian consumer shelf

As one Canadian guide describes it.

The main registered consumer rat poison is described as a bromethalin bait in tamper-resistant disposable stations, with loose bait and bulk blocks off-limits to homeowners.¹⁴¹⁰

23.0b And in stations only

Loose pellets, meal baits and place-packs are described as gone from domestic class shelves, which is the mitigation the whole structure depends on.¹⁰

23.1 Written by a company that does not treat rodents

The publisher states it is a mosquito and tick service that does not treat rats, which we note because its account of the shelf is commercial content.¹⁴

24. What a household should know

Our suggestions.

That consumer rat bait is now often a poison with no antidote, that a pet seen near a station should go to a veterinarian at once rather than after symptoms, and that the product packaging should go with them, since identification decides treatment.⁷⁵

24.0a And tell the veterinarian which product

The case report's call for accurate product identification applies in reverse too: an owner who brings the package spares the clinician the guess that went wrong in that case.⁷

24.0b And a station is not a guarantee

A dog can chew or crush a station, and a station knocked over or opened defeats its purpose, which is why placement where pets cannot reach matters even with a tamper-resistant design.

That advice is general and ours.

24.1 Time is the only treatment advantage

Early decontamination usually provides good outcomes, which makes the delay before symptoms the dangerous interval.⁵

25. Why this is not an argument for the old products

Our position.

Returning persistent anticoagulants to consumers would restore an antidote and the wildlife harm together. The better answer our exclusion articles keep reaching is fewer poisons in homes at all, which removes both risks at once.

25.0b Restoring one restores both

The antidote and the residue came together in the persistent compounds, and they would return together.

25.1 Nor for switching back and forth

Each class carries a risk the other avoids, and choosing between them is choosing which animal to put at risk, not whether to put any at risk at all.

25.2 Traps and exclusion avoid the choice

Which the Canadian guide also recommends as a first move for household problems, from a company with no rodent service to sell.¹⁴

26. What we take from it

Three things.

The trade-off our earlier article reasoned about was real and was predicted. Sections 10 and 11.⁵⁷

Neither class is simply safer. Section 17.⁵

And the structure put each risk with a different buyer. Section 19, which is our reading.

26.1 And one thing we cannot take from it

How many pets were poisoned because of the substitution, which none of the reporting systems we found can say.

27. Our own position

The disclosure.

This company sells rodent control, and as a licensed operator it sits on the side of the arrangement that kept access to the persistent compounds. This article describes consumer products and makes no claim about which products we use.

27.0b What we can say

That the chemistry a licensed operator can use is not the chemistry a householder can buy, and that the difference carries a wildlife risk on our side of the line and a pet risk on the other.

27.1 And it is not an argument for professional service

Professional baiting carries the wildlife risk our earlier article documented, which is the other half of the same trade-off.

28. The Manitoba position

28.1 The Canadian rules apply here

The domestic class prohibition and bait station requirement are federal, so the consumer shelf in this province follows them.⁸

28.1b And a cold province brings rodents indoors

Which is when households are most likely to place bait inside, where pets live, rather than outdoors where wildlife feed.

That seasonal point is our inference.

28.2 What we could not find

Any Canadian pet poison data on bromethalin, any Manitoba veterinary laboratory figures, and the content of the Canadian re-evaluation itself.

28.2b And our own articles have not tracked it

This journal has written at length about rodenticide resistance and wildlife residues, and until now only in passing about what consumer bait does to pets in the homes where it is placed.

28.3 Which leaves the Canadian pattern inferred

From similar products and a regulator that itself treated the two countries' use patterns as similar.⁹

29. Limitations and open questions

The data measure reports and submissions, not incidence. Poison control calls and laboratory submissions both depend on people recognising and reporting a case, and neither counts how many animals were poisoned.⁷²

That is the most important limitation because the direction of the shift is supported from three sources while its size is not established by any of them.

We found no Canadian figures. Every quantitative source is American, and §28 records that the Canadian pattern is inferred.

Several sources are secondary. A veterinary trade magazine, a professional association news item and a Canadian commercial guide supply important parts of the account, and the retail guide in particular has a commercial interest.¹⁵¹⁰

The Canadian dates conflict. Section 4.2 records two different dates for when the measures took effect.¹⁰¹¹

Sections 5, 8.1, 14, 18, 19, 20, 21, 24 and 25 are our reasoning. The reading of the structure as allocating risks between buyers and victims, the caution about submissions, and the household advice are ours rather than sourced positions.

30. Conclusion

Our earlier rodenticide article reasoned that the alternatives to persistent anticoagulants are gentler on wildlife and harsher on pets, because anticoagulant poisoning can be reversed with vitamin K and the alternatives cannot. Regulators then made that trade. In 2008 the American regulator removed second-generation anticoagulants from consumer products while leaving them available to professionals, and in 2010 the Canadian regulator prohibited them in domestic class products and required consumer bait in stations.⁶⁸ Consumer shelves in both countries filled with bromethalin, a neurotoxin that may cause cerebral oedema, developed in the 1970s against warfarin-resistant rodents, with no antidote.³¹⁰

The shift was predicted before it happened: a pet poison helpline said in 2013 that the public would sharply increase use of bromethalin products, and an animal welfare organisation warned of the same for bromethalin and cholecalciferol.⁵ Then it happened. Animal poison control data for 2010 to 2020 show those exposures rising and anticoagulant exposures falling; a veterinary reference states that bromethalin quickly became the most common rodenticide exposure in companion animals; and one laboratory system recorded a 2.8-fold rise in submitted cases.⁷³² The figures count reports and submissions rather than poisonings, so the direction is clear and the size is not. Bromethalin is also hard to diagnose, with normal routine tests and delayed signs, and the shift has changed what veterinarians expect, to the point that at least one anticoagulant case was first mistaken for it.¹⁷

The antidote advantage is not free either: persistent anticoagulant poisoning can require weeks or months of vitamin K and monitoring.⁵ So neither class is simply safer, and the regulators made a defensible choice to protect wildlife. What the choice produced is a structure in which professionals keep the persistent compounds and the antidote, and households keep the compound without one, secured only by the station it comes in. Each risk sits with a different buyer and falls on a different animal. The answer that removes both is fewer poisons in homes at all, which is the conclusion our exclusion articles keep reaching.

References

1. Article on bromethalin toxicosis in pets written by veterinary neurologists, published by a veterinary trade publication in 2026. Professional trade material. Source for the statements that after the regulator mandated consumer rodenticide restrictions, non-anticoagulants, primarily bromethalin, took over the marketplace and human and companion animal exposures rose; that intoxication is difficult to prove, signs may not develop for days and may progress slowly, and routine blood and urine tests are typically normal; and that the regulator mandates an indicator dye in consumer rodenticides, whose green-blue colour in vomit or faeces may imply ingestion. https://www.dvm360.com/view/veterinary-neurology-alert-bromethalin-toxicosis-rise-pets
2. Fourteen-year retrospective study of bromethalin exposure in dogs and cats from a state veterinary diagnostic laboratory system, published in a veterinary internal medicine journal in 2025 and read as an extract. Peer-reviewed material. Source for the account that the regulator began reviewing older rodenticides in 1988, proposed limiting second-generation anticoagulants to professional and some agricultural use a decade later and finalised the restriction in 2008, with increased sales of bromethalin products following; for the statement that human and animal exposure to bromethalin has risen since; for the 2.8-fold increase in submitted cases from 2010 to 2016 and 2017 to 2023, from 59 to 164; and for the findings that 25 per cent more dog than cat cases were submitted, with a median dog age of three years and cats significantly younger. https://onlinelibrary.wiley.com/doi/full/10.1111/jvim.70057
3. Veterinary reference entry on bromethalin poisoning in animals, published in a widely used veterinary manual and updated in 2026. Professional reference material. Source for the statements that bromethalin is a neurotoxin that may cause cerebral oedema and quickly became the most common rodenticide exposure in companion animals after enforcement of the regulator's risk mitigation measures began; that it was developed in the mid-1970s in response to warfarin-resistant rodents; that it is available in blocks, soft baits, pellets and other forms at concentrations from 0.01 to 0.025 per cent; and that non-target exposure is typically by direct ingestion of bait. https://www.merckvetmanual.com/toxicology/rodenticide-poisoning/bromethalin-poisoning-in-animals
4. Veterinary reference overview of rodenticide poisoning in animals, published in the same manual. Professional reference material. Source for the statements that resistance to first-generation anticoagulants led to both bromethalin and the second-generation anticoagulants, the latter with median lethal doses 2.5 to 200 times lower than first-generation products and greater risk to non-target species; and that the regulator drafted its risk mitigation decision for ten rodenticides in 2008 and attempted to implement it by 2011. https://www.merckvetmanual.com/toxicology/rodenticide-poisoning/overview-of-rodenticide-poisoning-in-animals
5. News article on changing rodenticide use and risks, published by a national veterinary association in 2013. Professional association news material. Source for the statement by the assistant director of veterinary services at a pet poison helpline that she expected the public to sharply increase use of bromethalin products if a major brand's anticoagulant products were removed, and her concern that veterinarians might not know bromethalin use was increasing or that its treatment is more difficult and expensive; for her description of treatment as repeated activated charcoal over 24 hours, with good outcomes from early treatment and possible permanent neurological damage in animals already showing signs; for the regulator's information that second-generation anticoagulants have long half-lives and treatment can require weeks or months of vitamin K and blood monitoring; and for an animal welfare organisation's concern that regulation of anticoagulants could increase use of bromethalin and cholecalciferol. https://www.avma.org/javma-news/2013-03-15/rodenticide-use-risks-may-change
6. Rodent control pesticide safety review page published by the American environmental regulator. Official government material. Source for the statements that manufacturers may no longer sell consumer products containing the four second-generation anticoagulants posing the greatest risk to non-target wildlife, that baits containing them may still be used in homes by pest control professionals, and that the 2008 risk mitigation decision for ten rodenticides included measures to reduce risks to human health and non-target organisms; and for the classification of rodenticides into first-generation anticoagulants, second-generation anticoagulants and non-anticoagulants including bromethalin and cholecalciferol. https://www.epa.gov/rodenticides/rodent-control-pesticide-safety-review
7. Case report on atypical neurological signs from anticoagulant rodenticide toxicosis in a dog, published in a veterinary journal and accessed through a public biomedical archive. Peer-reviewed case material. Source for the statements that since the regulator's 2008 ruling there has been a shift in the types of rodenticide toxicoses reported to a national animal poison control centre, with bromethalin and cholecalciferol exposures increasing and anticoagulant exposures decreasing between 2010 and 2020; that neurological signs in the reported dog were initially assumed to be bromethalin toxicosis but were found to result from a long-acting first-generation anticoagulant causing presumptive central nervous system haemorrhage; and that the change in consumer products in the United States and Canada highlights the need for accurate product identification in suspected toxicosis. https://pmc.ncbi.nlm.nih.gov/articles/PMC10581352
8. Review of second-generation anticoagulant rodenticides and risks to wildlife, published by a provincial government in 2021. Official provincial government material. Source for the statement that following the American decision the Canadian regulator required additional risk mitigation measures for eight rodenticides in 2010, under which second-generation anticoagulants were prohibited for domestic class products intended for consumer use in and around the home, while commercial class products containing them were labelled for use only by certified pest control operators, farmers and authorised programmes, with further restrictions on indoor and outdoor use. https://www2.gov.bc.ca/assets/gov/environment/pesticides-and-pest-management/legislation-consultation-new/rodenticide_science_review_2021.pdf
9. Page on use restrictions for commercial class rodenticides in agricultural settings, published by the federal health department. Official government material. Source for the statement that the protective measures cover several actives including bromethalin, result from an evaluation of risks and value, and that reports of incidental exposure from Canada and the United States were considered given the similar use patterns for these products in the two countries. https://www.canada.ca/en/health-canada/services/consumer-product-safety/reports-publications/pesticides-pest-management/fact-sheets-other-resources/rodenticides-agricultural-settings.html
10. Guide to mouse bait stations in Canada, published by a Canadian pest service company's product guide section in 2026. Commercial content material from a company stating that it provides mosquito and tick control and does not treat rodents, flagged. Source for the account that the Canadian risk mitigation rules took effect in January 2013 and removed second-generation anticoagulants from consumer shelves; that consumer products must be sold as pre-loaded tamper-resistant bait stations; that the main registered consumer poison is a bromethalin bait in disposable stations; and that bromethalin has no antidote and vitamin K does nothing for it. https://buzzskito.ca/blog/mouse-bait-station-canada
11. Frequently asked questions page on rodenticide availability, published by a home and garden products manufacturer. Manufacturer material, flagged. Source for the statement that after 30 June 2014 only domestic rodenticides conforming to the new federal requirements would be available at retail, including the prohibition of domestic class products containing second-generation anticoagulants. http://www.pthomeandgarden.com/frequently-asked-questions/why-cant-i-find-the-rat-mouse-bait-i-have-used-for-years/
12. The same fourteen-year laboratory study as published on a second academic platform, read for its reference list. Peer-reviewed material. Cited only for the titles in its reference list of a method for detecting desmethylbromethalin in animal tissue to determine bromethalin exposure, a retrospective study of 192 dogs from 2010 to 2016, and a study of medical outcomes of bromethalin exposures reported to American poison centres after the federal restriction of anticoagulants, none of which we read. https://academic.oup.com/jvim/article/39/3/jvim70057/8446874
13. Draft ecological risk assessment for bromethalin prepared by the American environmental regulator, reproduced on an industry website. Official regulatory document hosted by a third party, flagged. Source for the statement that bromethalin is fairly fast-acting, with signs of toxicity within the first 24 hours of exposure and death two to four days later. https://responsiblerodenticides.org/wp-content/uploads/2022/08/EPA-Draft-Ecological-Risk-Assessment-Bromethalin.pdf
14. Guide to which rat poisons are legal for Canadian consumers, published by the same Canadian pest service company as reference 10 in 2026. Commercial content material, flagged; the page includes affiliate links. Source for the statement that a bromethalin disposable bait station is the main registered consumer rat poison in Canada; for the statement that there is no antidote for bromethalin; and for the publisher's statement that it is a mosquito and tick control service that does not treat rats. https://buzzskito.ca/blog/rat-poison-canada-what-is-legal